Christine Jessop’s killer identified: Solved cold case raises questions about genetic privacy
By Julia Creet,
The Conversation
| 10. 22. 2020
On Oct. 15, Toronto police announced that they had finally solved the 1984 murder of Christine Jessop using DNA evidence and genetic genealogy websites. Identifying Calvin Hoover as Jessop’s killer has provided immense relief to the family and those close to the case, and in particular to Guy Paul Morin, who was wrongfully convicted and later exonerated after serving 18 months in prison.
The announcement highlights a conundrum: at risk is the genetic privacy of everyone who has uploaded — and, mostly, not uploaded — a DNA sample to a commercial genealogy site.
Genealogists never anticipated that their benign but passionate interest in tracking relations through records and DNA would ever lead to law enforcement’s most potent cold case tool kit. In 2018, public awareness of law enforcement’s mining of genetic genealogy came to light with the 2018 identification of the Golden State Killer. The identification of Joseph James DeAngelo relied on freely uploaded DNA results alongside painstaking genealogical research.
Data industry
Since then, law enforcement’s mining of genealogical data has become an industry in itself, with hundreds...
Related Articles
By Katie Palmer and Usha Lee McFarling, Stat | 09.03.2024
Photo by Hush Naidoo Jade Photography on Unsplash
Pediatrician Alexandra Epee-Bounya had had enough. In her 20 years caring for children in Boston, she had seen hundreds of kids with suspected urinary tract infections. Each time, she’d turn to a...
By Emily R. Klancher Merchant, Los Angeles Review of Books | 08.22.2024
IN THE Operation Varsity Blues scandal of 2019, 50 wealthy parents were charged with trying to get their children into elite universities through fraudulent means. The story dramatically demonstrated the lengths to which some parents will go to ensure their...
By Julia Brown, The Conversation | 08.16.2024
With their primary goal to advance scientific knowledge, most scientists are not trained or incentivized to think through the societal implications of the technologies they are developing. Even in genomic medicine, which is geared toward benefiting future patients, time and...
By Antonio Regalado, MIT Technology Review | 08.22.2024
In 2016, I attended a large meeting of journalists in Washington, DC. The keynote speaker was Jennifer Doudna, who just a few years before had co-invented CRISPR, a revolutionary method of changing genes that was sweeping across biology labs because...